Literature DB >> 3087499

Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

C M Taylor, R H White, M H Winterborn, B Rowe.   

Abstract

In 1982-3, 35 children from the West Midlands developed the haemolytic-uraemic syndrome. This was a higher incidence than expected and included an epidemic localised to the Wolverhampton area in July 1983 which comprised 11 cases in two weeks. Twenty three children were treated with dialysis, of whom three died. Six patients developed chronic renal failure, four of them from Wolverhampton. Extrarenal manifestations included neurological sequelae in four, two of whom also developed insulin dependent diabetes mellitus and chronic renal failure. Cardiomyopathy occurred in one child, who also had chronic renal failure. The outcome of these 35 patients was not predictable from prognostic criteria derived from previous experience in Britain. This, together with the high prevalence of extrarenal disease and the geographical localisation of the 1983 outbreak, suggested an aetiological agent new to the region. Faeces from 10 patients were examined for verotoxin producing Escherichia coli, and positive strains of serotype O157.H7 were found in three patients during the Wolverhampton outbreak.

Entities:  

Mesh:

Year:  1986        PMID: 3087499      PMCID: PMC1340507          DOI: 10.1136/bmj.292.6534.1513

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  16 in total

1.  Hemolytic-uremic syndrome.

Authors:  E Lieberman
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

2.  An analysis of the results of therapy in 67 cases of the hemolytic-uremic syndrome.

Authors:  B S Kaplan; J Katz; S Krawitz; A Lurie
Journal:  J Pediatr       Date:  1971-03       Impact factor: 4.406

3.  Clinical and pathological aspects of central nervous system involvement in the haemolytic uraemic syndrome.

Authors:  J C Rooney; R M Anderson; I J Hopkins
Journal:  Aust Paediatr J       Date:  1971-03

4.  Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndrome.

Authors:  P E Rose; J A Armour; C E Williams; F G Hill
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

5.  Escherichia coli O:H serotypes isolated from human blood. Prevalence of the K1 antigen with technical details of O and H antigenic determination.

Authors:  F Orskov; I Orskov
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1975-12

6.  Pancreatic islet cell necrosis: association with hemolytic-uremic syndrome.

Authors:  J C Burns; E R Berman; J L Fagre; R H Shikes; G M Lum
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

7.  Haemolytic-uraemic syndrome. A report of an outbreak.

Authors:  M M McLean; C H Jones; D A Sutherland
Journal:  Arch Dis Child       Date:  1966-02       Impact factor: 3.791

8.  Development of insulin-dependent diabetes mellitus during the hemolytic-uremic syndrome.

Authors:  S P Andreoli; J M Bergstein
Journal:  J Pediatr       Date:  1982-04       Impact factor: 4.406

9.  CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis.

Authors:  J F Bale; C Brasher; R L Siegler
Journal:  Am J Dis Child       Date:  1980-09

10.  Thrombolytic therapy in haemolytic--uraemic syndrome.

Authors:  J Stuart; M H Winterborn; R H White; R M Flinn
Journal:  Br Med J       Date:  1974-07-27
View more
  46 in total

Review 1.  New insights into the haemolytic uraemic syndromes.

Authors:  D V Milford; C M Taylor
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

2.  Azithromycin decolonization of STEC--a new risk emerges.

Authors:  Michael E Seifert; Phillip I Tarr
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

3.  The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.

Authors:  H Kleanthous; N K Fry; H R Smith; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1988-10       Impact factor: 2.451

Review 4.  Causes of the haemolytic uraemic syndrome.

Authors:  J Kavi; R Wise
Journal:  BMJ       Date:  1989-01-14

5.  Clinical and pathological variability of infection by enterohaemorrhagic (Vero cytotoxin producing) Escherichia coli.

Authors:  C M Hunt; J A Harvey; E R Youngs; S T Irwin; T M Reid
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

6.  Transient glucose intolerance associated with the haemolytic-uraemic syndrome.

Authors:  S F Zeidan; M G Coulthard
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

7.  Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure.

Authors:  Varvara Askiti; Kristine Hendrickson; Alfred J Fish; Elizabeth Braunlin; Alan R Sinaiko
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

8.  The use of serodiagnosis in the retrospective investigation of a nursery outbreak associated with Escherichia coli O157:H7.

Authors:  T Cheasty; R Robertson; H Chart; P Mannion; Q Syed; R Garvey; B Rowe
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

9.  Diarrhea-associated hemolytic uremic syndrome.

Authors:  W L Robson; A K Leung; C L Trevenen; R Brant
Journal:  Can Fam Physician       Date:  1993-10       Impact factor: 3.275

10.  Myocarditis and haemolytic uraemic syndrome.

Authors:  I Abu-Arafeh; E Gray; G Youngson; I Auchterlonie; G Russell
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.